Mark Lambie

Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference

Andrew S. Levey, Kai‐Uwe Eckardt, Nijsje Dorman et al. · Kidney International · 2020 · 676 citations · Full text

Glomerulonephritis, Hemodialysis, Renal Function +13

Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation

Ceri A. Fielding, Gareth W. Jones, Rachel M. McLoughlin et al. · Immunity · 2014 · 359 citations · Full text

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Independent Effects of Systemic and Peritoneal Inflammation on Peritoneal Dialysis Survival

Mark Lambie, James Chess, Kieron Donovan et al. · Journal of the American Society of Nephrology · 2013 · 187 citations · Full text

Immunology, Dialysis Therapy, Inflammation +17